Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

The ongoing construction, and overall cost, of parks in downtown Jacksonville continue to be big- budget items. What's ...

The West of England P&I Club has announced the appointment of Bart Mertens as its new chief underwriting officer (CUO). He ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

It’s easy, amid all the destruction and suffering in Gaza, to overlook what is happening as little as 34 miles away in the Israeli-occupied West Bank. For much of the past 11 months—during ...

The best point and shoot camera will be affordable, have the ability to shoot photos and videos, and be very compact When you purchase through links on our site, we may earn an affiliate commission.

(Photo by Adam Fradgley/West Bromwich Albion FC via Getty Images ... The hosts’ rapid start to the game had waned by this point, but the move was stunning. It started with keeper Alex Palmer ...

Erling Haaland struck a stunning second successive hat-trick to fire Pep Guardiola‘s reigning champions to an emphatic victory at the London Stadium and maintain our perfect start to the new Premier ...

The Gunners had to settle for a point earlier on Saturday after Declan ... What a diamond he is. West Ham - who sit in 13th place on three points - might have conceded from City's first attack ...

Report and free match highlights as Manchester City make it three wins from their opening three Premier League games by seeing off a spirited West Ham ... to settle for a point earlier on Saturday ...

During a trip to the West Bank to conduct research and visit her family in Nablus in 2022, Yara Asi remembered the moments when Israel’s military besieged the city, a major economic hub for the ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...